logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Weight-Loss Truce: Hims & Hers Wins Novo Nordisk Deal, Soars 40%

Weight-Loss Truce: Hims & Hers Wins Novo Nordisk Deal, Soars 40%

Mar 9, 2026

Life Science

This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off?

This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off?

Mar 8, 2026

Life Science

高股息医疗股怎么选?强生与美敦力的优势与挑战

Alleviating Doctors’ Paperwork, Amazon Accelerates AI Healthcare Initiatives

Mar 5, 2026

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Amtagvi’s Complex Path: Why Iovance Is Either a Home Run or a Strikeout

Mar 5, 2026

Life Science

Down 35% This Year, Alnylam Still Has Wall Street Calling 44% Upside

Post-Casgevy Era: CRISPR’s Quandary vs. Vertex’s Moat

Mar 4, 2026

Life Science

Buffett’s UnitedHealth Bet Pays Off as Insurer Crushes Q1 Estimates

Despite Gains, These 2 Stocks Are Still Worth Buying

Mar 4, 2026

Consumer Goods, Life Science

WIX, MSFT, GOOGL, AMZN, TSLA: AI tape lights up

Mar 4, 2026

Consumer Goods, Life Science

Buffett’s AXP Holding Drops — Is Now the Time to Buy?

Why Novartis Outshines Amarin as a Safe Bet in a Volatile Market

Mar 3, 2026

Life Science

7 Dividend Stocks and ETFs to Hold Forever in the U.S. Market

Decoding the 2026 Market Leaders: 6 Stocks That Have Already Doubled

Mar 2, 2026

Energy, Life Science, Technology

Goldman Sachs Adds Vertex to Conviction List With $653 Target

Teva’s Earnings Beat, Stock Doubles: Buy, Sell, or Hold?

Mar 2, 2026

Life Science

Shattuck Labs Jumps as Two Analysts Start Bullish Coverage

Eli Lilly Soars, Regencell Speculates, but Pfizer’s 6.4% Yield Makes It the Real Value Play

Mar 1, 2026

Life Science

到2030年,这些股票可能是表现最佳的生物科技股

Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse

Feb 26, 2026

Life Science

Long-Term Case for Aritzia, BMO, MDA, Dollarama Amid BoC Caution

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Feb 26, 2026

Life Science

Germany Drone Bet Puts RHM GY, HAG GY in Focus

Feb 26, 2026

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Following Billionaire Laffont? Analyzing the Investment Thesis for Moderna

Feb 25, 2026

Life Science

Lilly and Viking Just Showed the Obesity Market's Next Phase — and It's Not About Pounds

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Feb 25, 2026

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy

Feb 24, 2026

Life Science

Medicines Made for Life. | Aytu BioPharma (Nasdaq: AYTU)

Feb 24, 2026

Life Science

  • ‹‹ Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada